SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Unjha Formulations - Quaterly Results

02 May 2022 Evaluate
A decent increase of about 36.22% in the sales to Rs. 42.95 millions was observed for the quarter ended March 2022. The sales figure stood at Rs. 31.53 millions during the year-ago period.The Net Loss for the quarter ended March 2022 is Rs. -0.62 millions as compared to Net Loss of Rs. -2.55 millions of corresponding quarter ended March 2021 Operating profit Margin for the quarter ended March 2022 improved to 1.22% as compared to -0.73% of corresponding quarter ended March 2021


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202203 202103 % Var 202203 202103 % Var 202203 202103 % Var
Sales 42.95 31.53 36.22 143.51 101.72 41.08 143.51 101.72 41.08
Other Income 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBIDT 1.22 -0.73 -267.12 5.09 3.58 42.18 5.09 3.58 42.18
Interest 1.19 1.62 -26.54 1.32 1.73 -23.70 1.32 1.73 -23.70
PBDT 0.03 -2.35 -101.28 3.77 1.85 103.78 3.77 1.85 103.78
Depreciation 0.18 0.20 -10.00 0.76 0.81 -6.17 0.76 0.81 -6.17
PBT -0.15 -2.55 -94.12 3.01 1.04 189.42 3.01 1.04 189.42
TAX 0.47 0.00 0.00 0.47 0.00 0.00 0.47 0.00 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT -0.62 -2.55 -75.69 2.54 1.04 144.23 2.54 1.04 144.23
Equity 44.81 44.81 0.00 44.81 44.81 0.00 44.81 44.81 0.00
PBIDTM(%) 2.84 -2.32 -222.68 3.55 3.52 0.78 3.55 3.52 0.78

Unjha Formulations Share Price

20.95 0.00 (0.00%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1676.00
Dr. Reddys Lab 1234.90
Cipla 1239.00
Zydus Lifesciences 947.70
Lupin 2332.55
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×